HB8319, the KIDNEY Remote Monitoring Act, would amend the Medicare statute to expand payment for remote physiologic monitoring services for people with end stage renal disease who receive home dialysis. The bill directs that, beginning January 1, 2028, when a physician furnishes remote physiologic monitoring services to such a patient, Medicare payment would be made under the physician fee schedule methodology in section 1848 of the Social Security Act.
The measure is narrowly focused on dialysis patients and is intended to support year-round remote oversight of individuals managing kidney failure at home. By tying payment to an existing Medicare payment framework, the bill seeks to create a clearer reimbursement pathway for physicians providing remote monitoring to this population.
Impact
The bill would amend section 1881(b)(3) of the Social Security Act, changing how Medicare pays for certain remote physiologic monitoring services for beneficiaries with end stage renal disease receiving home dialysis. It would expand the statutory basis for payment and align reimbursement with the physician fee schedule for services furnished on or after January 1, 2028. The practical effect would be to affect Medicare providers, home dialysis patients, and potentially telehealth/remote monitoring vendors supporting kidney care.
Sentiment
There is no recorded committee debate, vote, or opposition in the provided materials, so the available sentiment appears neutral to favorable. The bill’s sponsors from both parties suggest bipartisan interest in improving access to monitoring for dialysis patients. The title and structure of the bill indicate a targeted, technical Medicare policy change rather than a broad or controversial overhaul.
Contention
No specific points of contention are documented in the provided transcripts or voting history. Potential issues that could arise in consideration include Medicare spending, implementation timing, and whether remote physiologic monitoring should be expanded through the physician fee schedule for this patient group. Any debate would likely center on reimbursement policy, administrative complexity, and the scope of eligible services rather than the underlying goal of supporting home dialysis patients.